Medical News

RSS

White House and Bishops at odds over abortion

"The White House is on a collision course with Catholic bishops in an intractable dispute over abortion that could blow up the fragile political coalition behind President Barack Obama's health care overhaul," the Associated Press reports.

20 Nov 2009

A selection of today's opinions and editorials

These bills will provide a bedrock sense of security and stability for Americans who have health insurance, and quality, affordable options for Americans without it (Peter R. Orszag, 11/20).

20 Nov 2009

Poll: Majority of Americans support medical malpractice reform

The Associated Press further analyzed its poll from earlier this week, with an eye on medical malpractice limits: "54 percent favor making it harder to sue doctors and hospitals for mistakes taking care of patients, while 32 percent are opposed. The rest are undecided or don't know. But congressional Democrats are reluctant to press forward on the issue. They don't want to upset a valuable political constituency — trial lawyers — even if President Barack Obama says he believes that fear of being sued leads doctors to practice defensive medicine, driving up costs for everyone."

20 Nov 2009

UCH’s Cardiac & Vascular Center now offers treatment with CardiacAssist's TandemHeart System

CardiacAssist Inc. announced today that the University of Colorado Hospital (UCH) has adopted the company’s TandemHeart® System.

20 Nov 2009

Policy flashpoints fuel reform debate

Kaiser Health News: "The health care overhaul debate in Congress now centers on two bills: the House-passed measure and the Senate Democrats' version unveiled Wednesday. They differ in important ways." KHN provides a consumers' guide that discusses mandates, new regulations on health insurers and how the legislation would affect both the insured and uninsured (Appleby, Carey, Galewitz and Rau, 11/19).

20 Nov 2009

California issues strict rules for health professionals with addiction problems

News outlets report on a variety of health issues at the state level including stricter rules for drug abusers in the health industry in California, an examination of the nation's first city-run universal health care plan in San Francisco, a cigarette tax in Florida, sex offenders and ex-convicts in nursing homes in Illinois and efforts to battle medical errors in New Jersey.

20 Nov 2009

Biotel reports net earnings of $128,000 for its first quarter ended September 30, 2009

Biotel Inc. announced results for its first quarter ended September 30, 2009 with net earnings of $128,000, or $0.04 per diluted share, on revenues of $3,263,000. This compares to net earnings of $328,000, or $0.11 per diluted share, on revenues of $3,168,000 for the first quarter of last year.

20 Nov 2009

Tax provisions in Senate health bill draw scrutiny

Several news organizations report on new taxes in the Senate health bill and how they differ from those in the House-passed measure.

20 Nov 2009

Impax Laboratories implements IBM's business analytics technology

IBM announced today that Impax Laboratories, Inc., a technology-based specialty pharmaceutical company, is using IBM business analytics technology to gain stronger insights into their business and better predict risks and market opportunities.

20 Nov 2009

Discus Dental launches its newly redesigned Zoom Chairside Whitening Kit

Discus Dental®, LLC today announced the release of its newly redesigned Zoom® Chairside Whitening Kit, improving overall procedure ease of use and safety by reducing the total number of steps in the Zoom procedure.

20 Nov 2009

House moves to block doctors' Medicare pay cuts

The House voted largely along party lines Thursday to permanently end annual cuts in doctors' Medicare payments, which the Congress has temporarily averted from year to year, the Associated Press reports. The legislation would add more than $200 billion to the deficit, and Republicans "contended that Democrats supported the bill to thank the [American Medical Association] for backing President Barack Obama's health care overhaul."

20 Nov 2009

CVS/pharmacy kicks off its fundraiser for St. Jude Children's Research Hospital's annual campaign

CVS/pharmacy kicks off its annual in store fundraiser for the sixth year to support the St. Jude Children's Research Hospital Thanks and Giving campaign, beginning this Sunday and running through December 12. CVS/pharmacy store colleagues will encourage customers to add $1 to their purchase at the register to support the lifesaving research of St. Jude, one of the world's premier centers for the research and treatment of pediatric cancer and other catastrophic childhood diseases.

20 Nov 2009

'Botax' on cosmetic surgery questioned

The Associated Press: "The White House and Senate Democrats have turned to a proposal to tax breast implants, tummy tucks, wrinkle-smoothing injections and other procedures as they search for ways to pay for costly health care overhaul plans." The Senate health bill, which was unveiled Wednesday by Senate Majority Leader Harry Reid of Nevada "would slap a 5 percent excise tax on elective cosmetic surgeries and procedures to help pay for expanding coverage to the uninsured."

20 Nov 2009

Smartfish Technologies' patented ErgoMotion technology unveiled

Today, Smartfish Technologies launched its long-awaited ErgoMotion(TM) technology, the first ever design that combines the science of ergonomics with the technology of motion, resulting in a dramatic change and improvement in the way comfort is integrated into devices like mice and keyboards. Unveiled yesterday at Pepcom’s annual Wine, Dine and Demo event, ErgoMotion is the industry’s most advanced computer peripheral solution designed to relieve discomfort and repetitive stress injuries (RSI) related to extended computer usage.

20 Nov 2009

Olbermann ties free clinics to health reform

"A nonprofit group's campaign to hold free medical clinics for the uninsured in three states is turning into a not-so-subtle jab at moderate Democrats to support their party's efforts to reform health care," The Associated Press reports. "More than 800 people have signed up for free care Saturday at a downtown convention center in Little Rock at an event organized by the National Association of Free Clinics — the Virginia-based association's second free event in the past month under a campaign promoted by MSNBC's Keith Olbermann."

20 Nov 2009

GOP and industry groups quick to decry Senate health bill

When Senate Democrats unveiled a bill meant to expand health coverage and restrain spending growth, "Republicans saw little to like," The Associated Press reports. GOP senators characterized the package Thursday "as a collection of tax increases, Medicare cuts and heavy new burdens for deficit-ridden states." Meanwhile, Republican governors fretted that the bill would expand Medicaid, a program that insures the poor, and relies on states for a portion of its funding. "We all know a sucker play when we see one," said Indiana Gov. Mitch Daniel (Espo, 11/20).

20 Nov 2009

Quest Diagnostics announces final results of its cash tender offer

Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, announced today the final results for its previously announced cash tender offer (the "Tender Offer") to purchase any and all of its 5.125% Senior Notes due 2010 and any and all of its 7.50% Senior Notes due 2011 (collectively, the "Notes").

From Quest Diagnostics 20 Nov 2009

Antigenics to withdraw its MAA for Oncophage following CHMP’s negative opinion

Antigenics Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMEA), has formally adopted a negative opinion on the marketing authorization application (MAA) for Oncophage (vitespen) as a treatment in earlier-stage, localized renal cell carcinoma (kidney cancer).

20 Nov 2009

FDA acknowledges Dendreon's amended BLA for PROVENGE as a complete response

Dendreon Corporation today announced that the U.S. Food and Drug Administration (FDA) provided written acknowledgement that the Company's amended Biologics License Application (BLA) for PROVENGE® (sipuleucel-T) is a complete response. The FDA has assigned a Prescription Drug User Fee Act (PDUFA) date of May 1, 2010, by which time it will respond to Dendreon's amended BLA. Dendreon is seeking licensure for PROVENGE for men with metastatic castrate-resistant prostate cancer (CRPC).

20 Nov 2009

Pfizer’s Revatio Injection receives FDA approval

Pfizer announced today that the U.S. Food and Drug Administration (FDA) has approved Revatio® (sildenafil) Injection, an intravenous formulation of Revatio. Revatio is the only FDA-approved phosphodiesterase-5 (PDE5) inhibitor available in both tablet and intravenous formulations.

20 Nov 2009